Case Study

Synthetic Biology Company Hits Tech-Transfer Ready Targeted Timeline

Source: RoosterBio
GettyImages-1297146235-dna

A next generation therapeutics company was looking to develop a novel gene modified cell-based therapy that can be delivered to patients as efficiently and safely as possible.

To navigate through the complex product and process development stages of this novel therapeutic, their team needed to find the right partner who can provide them with cellular starting materials for MSC manufacturing and has the expertise to help them create a robust process that can produce a successful product.

RoosterBio supplied off-the-shelf RUO and cGMP hMSC starting materials in formats that accelerated their product and process development efforts. By working closely with the Company team, RoosterBio helped train their scientists and develop a manufacturing process that met their production needs for a Phase I requirement.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: